1.25 / AMA PRA Category 1 Credit(s)TM 1.25 / CE for Pharmacists
Jointly provided by Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare
In Collaboration With
The American Academy of HIV Medicine, the International Association of Providers of AIDS Care, and the University of Liverpool.
Supported by an educational grant from Viiv Healthcare
Because patients with HIV/AIDS are now living longer than ever before and taking antiretroviral therapy for decades, maximizing the safety and tolerability of treatment while preventing the development of resistance remains a high-stakes balancing act. As newer 2-drug regimens are now poised to challenge the standard of care for newly diagnosed individuals, clinicians must be knowledgeable of these options and prepared to incorporate them into practice. A small but important group of HIV-infected patients who also urgently require clinical attention are those considered “heavily treatment–experienced,” many of whom are failing on their current therapeutic regimen.
HIV specialists, pharmacists, and primary care clinicians (MDs/DOs, physician assistants [PAs], and nurse practitioners [NPs]) who treat patients with HIV disease
At the conclusion of this activity, participants should be better able to:
Describe and apply to practice recent data supporting the efficacy of dual-therapy regimens for initial treatment of HIV infection
Implement individualized therapeutic regimens that meet the needs of diverse patients with HIV while minimizing the risk for development of treatment resistance
Employ effective, evidence-based care plans for heavily treatment–experienced patients with HIV
Conflict Of Interest Disclosure Policies
In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare, require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. Haymarket Medical Education and AKH Inc. resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities.
MODERATOR David Alain Wohl, MD The University of North Carolina School of Medicine Site Leader, HIV Prevention and Treatment Clinical Research Site Chapel Hill, NC
Dr. Wohl receives consulting fees from Gilead Sciences, Inc., Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare.
FACULTY PRESENTERS Eric S. Daar, MD Professor of Medicine David Geffen School of Medicine University of California Los Angeles Los Angeles, CA
Dr. Daar receives consulting fees from Gilead Sciences, Inc., and receives grant/research funding from Gilead Sciences, Inc., Merck and Co., Inc., and ViiV Healthcare.
Jürgen Rockstroh, MD Professor of Medicine Department of Medicine University Hospital Bonn Bonn, Germany
Dr. Rockstroh receives consulting fees from Abivax, Gilead Sciences, Inc., Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare and is on the speakers’ bureaus of Gilead Sciences, Inc. and Merck and Co., Inc.
Paul E. Sax, MD Clinical Director, Division of Infectious Diseases Brigham and Women’s Hospital Professor of Medicine Harvard Medical School Boston, MA
Dr. Sax receives consulting fees from Gilead Sciences, Inc., Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare and is a principal investigator for Gilead Sciences, Inc. and ViiV Healthcare.
Babafemi O. Taiwo, MBBS Gene Stollerman Professor of Medicine Chief, Division of Infectious Diseases Northwestern University Feinberg School of Medicine Chicago, IL
Dr. Taiwo receives consulting fees from GlaxoSmithKline (GSK), Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare.
Laura Waters, FRCP, MD Consultant Physician, Sexual Health & HIV Mortimer Market Centre, Central & North West London NHS Trust London, UK
Dr. Waters receives consulting fees from Gilead Sciences, Inc., Janssen Therapeutics, MSD, Mylan, and ViiV Healthcare and is on the speakers’ bureaus of Gilead Sciences, Inc. and ViiV Healthcare.
Ms. Duffy has no financial relationships to disclose.
Accredited Provider Disclosures
Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education (HME) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 CreditsTM  to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has mutual recognition agreements with the AMA for live events and e-learning materials.
CE for Pharmacists
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AKH Inc., Advancing Knowledge in Healthcare (AKH) approves this knowledge-based activity for 1.25 contact hours (0.125 CEUs). UAN 0077-9999-19-042-H04-P. Initial release date: 7/31/2019.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 Credit for completing this activity.
Nurse Practitioner Continuing Education AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, AKH Inc., or ViiV Healthcare. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.